These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

300 related items for PubMed ID: 22892122

  • 1. Long-term benefits of immunoadsorption in β(1)-adrenoceptor autoantibody-positive transplant candidates with dilated cardiomyopathy.
    Dandel M, Wallukat G, Englert A, Lehmkuhl HB, Knosalla C, Hetzer R.
    Eur J Heart Fail; 2012 Dec; 14(12):1374-88. PubMed ID: 22892122
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Role of β₁-adrenoceptor autoantibodies in the pathogenesis of dilated cardiomyopathy.
    Dandel M, Wallukat G, Potapov E, Hetzer R.
    Immunobiology; 2012 May; 217(5):511-20. PubMed ID: 21820755
    [Abstract] [Full Text] [Related]

  • 4. Immunoadsorption therapy for dilated cardiomyopathy and pulmonary arterial hypertension.
    Dandel M, Wallukat G, Englert A, Hetzer R.
    Atheroscler Suppl; 2013 Jan; 14(1):203-11. PubMed ID: 23357166
    [Abstract] [Full Text] [Related]

  • 5. Reduction of morbidity by immunoadsorption therapy in patients with dilated cardiomyopathy.
    Knebel F, Böhm M, Staudt A, Borges AC, Tepper M, Jochmann N, Wernicke KD, Felix S, Baumann G.
    Int J Cardiol; 2004 Dec; 97(3):517-20. PubMed ID: 15561342
    [Abstract] [Full Text] [Related]

  • 6. Long-term prognostic impact of therapeutic strategies in patients with idiopathic dilated cardiomyopathy: changing mortality over the last 30 years.
    Merlo M, Pivetta A, Pinamonti B, Stolfo D, Zecchin M, Barbati G, Di Lenarda A, Sinagra G.
    Eur J Heart Fail; 2014 Mar; 16(3):317-24. PubMed ID: 24464640
    [Abstract] [Full Text] [Related]

  • 7. Improving survival rates of patients with idiopathic dilated cardiomyopathy in Tuscany over 3 decades: impact of evidence-based management.
    Castelli G, Fornaro A, Ciaccheri M, Dolara A, Troiani V, Tomberli B, Olivotto I, Gensini GF.
    Circ Heart Fail; 2013 Sep 01; 6(5):913-21. PubMed ID: 23888044
    [Abstract] [Full Text] [Related]

  • 8. Impact of troponin I-autoantibodies in chronic dilated and ischemic cardiomyopathy.
    Doesch AO, Mueller S, Nelles M, Konstandin M, Celik S, Frankenstein L, Goeser S, Kaya Z, Koch A, Zugck C, Katus HA.
    Basic Res Cardiol; 2011 Jan 01; 106(1):25-35. PubMed ID: 20957484
    [Abstract] [Full Text] [Related]

  • 9. Ig apheresis for the treatment of severe DCM patients.
    Pokrovsky SN, Ezhov MV, Safarova MS, Saidova MA, Shitov VN, Afanasieva MI, Khaustov AI, Adamova IY, Afanasieva OI, Konovalov GA.
    Atheroscler Suppl; 2013 Jan 01; 14(1):213-8. PubMed ID: 23357167
    [Abstract] [Full Text] [Related]

  • 10. Long-term outcome of high-urgency heart transplant patients with and without temporary ventricular assist device support.
    Castel MA, Cartañá R, Cardona M, Pereda D, Hernández M, Sandoval E, Castella M, Pérez-Villa F.
    Transplant Proc; 2012 Nov 01; 44(9):2642-4. PubMed ID: 23146481
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Aptamer neutralization of beta1-adrenoceptor autoantibodies isolated from patients with cardiomyopathies.
    Haberland A, Wallukat G, Dahmen C, Kage A, Schimke I.
    Circ Res; 2011 Oct 14; 109(9):986-92. PubMed ID: 21868696
    [Abstract] [Full Text] [Related]

  • 13. Effects of immunoadsorption and subsequent immunoglobulin G substitution on cardiopulmonary exercise capacity in patients with dilated cardiomyopathy.
    Herda LR, Trimpert C, Nauke U, Landsberger M, Hummel A, Beug D, Kieback A, Dörr M, Empen K, Knebel F, Ewert R, Angelow A, Hoffmann W, Felix SB, Staudt A.
    Am Heart J; 2010 May 14; 159(5):809-16. PubMed ID: 20435190
    [Abstract] [Full Text] [Related]

  • 14. Hemodynamic improvement and removal of autoantibodies against beta1-adrenergic receptor by immunoadsorption therapy in dilated cardiomyopathy.
    Mobini R, Staudt A, Felix SB, Baumann G, Wallukat G, Deinum J, Svensson H, Hjalmarson A, Fu M.
    J Autoimmun; 2003 Jun 14; 20(4):345-50. PubMed ID: 12791320
    [Abstract] [Full Text] [Related]

  • 15. Potential role of autoantibodies belonging to the immunoglobulin G-3 subclass in cardiac dysfunction among patients with dilated cardiomyopathy.
    Staudt A, Böhm M, Knebel F, Grosse Y, Bischoff C, Hummel A, Dahm JB, Borges A, Jochmann N, Wernecke KD, Wallukat G, Baumann G, Felix SB.
    Circulation; 2002 Nov 05; 106(19):2448-53. PubMed ID: 12417541
    [Abstract] [Full Text] [Related]

  • 16. Acute hemodynamic effects during immunoadsorption in patients with dilated cardiomyopathy positive for beta 1-adrenoceptor autoantibodies.
    Christ T, Dobrev D, Wallukat G, Schüler S, Ravens U.
    Methods Find Exp Clin Pharmacol; 2001 Apr 05; 23(3):141-4. PubMed ID: 11523313
    [Abstract] [Full Text] [Related]

  • 17. The predictive values of beta1-adrenergic and M2 muscarinic receptor autoantibodies for sudden cardiac death in patients with chronic heart failure.
    Pei J, Li N, Chen J, Li X, Zhang Y, Wang Z, Zhang P, Cao K, Pu J.
    Eur J Heart Fail; 2012 Aug 05; 14(8):887-94. PubMed ID: 22713286
    [Abstract] [Full Text] [Related]

  • 18. Midterm follow-up of patients who underwent removal of a left ventricular assist device after cardiac recovery from end-stage dilated cardiomyopathy.
    Hetzer R, Müller JH, Weng YG, Loebe M, Wallukat G.
    J Thorac Cardiovasc Surg; 2000 Nov 05; 120(5):843-53. PubMed ID: 11044309
    [Abstract] [Full Text] [Related]

  • 19. Therapeutic effect of immunoadsorption and subsequent immunoglobulin substitution in patients with dilated cardiomyopathy: Results from the observational prospective Bad Berka Registry.
    Ohlow MA, Brunelli M, Schreiber M, Lauer B.
    J Cardiol; 2017 Feb 05; 69(2):409-416. PubMed ID: 27890513
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.